Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Mikio Yamaguchi"'
Autor:
Mikio, YAMAGUCHI
Publikováno v:
研究紀要 短期大学部. 33:7-11
Autor:
Mikio, YAMAGUCHI
Publikováno v:
研究紀要 短期大学部. 32:9-13
Autor:
Mikio, YAMAGUCHI
Publikováno v:
研究紀要. 短期大学部. 30:27-31
Publikováno v:
研究紀要. 短期大学部. 30:33-38
Autor:
Mikio, YAMAGUCHI
Publikováno v:
研究紀要. 第四分冊, 短期大学部(III). 29:9-13
Autor:
Mikio, YAMAGUCHI
Publikováno v:
研究紀要. 第四分冊, 短期大学部(III). 28:11-18
Autor:
Makoto Kosai, Ikuji Kawata, Shuji Okada, Junji Koda, Mikio Yamaguchi, Yasuo Ishitani, Yohji Hori, Koichiro Sakamaki, Hiroyuki Hiramoto, Akio Kondo, Takaaki Shimada, Yasuo Koike, Shin-ya Ohtsu, Tatsuya Ishida, Naoya Takeda, Atsushi Mabuchi, Kuniharu Agawa, Ritsuko Abe
Publikováno v:
Practica Oto-Rhino-Laryngologica. 87:569-578
Roxithromycin (RXM) was administered to 191 patients with chronic paranasal sinusitis. The overall rate of excellent and good clinical response was 58.1% as judged by the attending otolaryngologists and 56.0% as judged by the committee.In bacteriolog
Autor:
Takaaki Shimada, Naoya Takeda, Koichiro Sakamaki, Hiroyuki Hiramoto, Atsushi Mabuchi, Shin-ya Ohtsu, Kuniharu Agawa, Yohji Hori, Junji Koda, Shuji Okada, Ritsuko Abe, Tatsuya Ishida, Mikio Yamaguchi, Akio Kondo, Makoto Kosai, Ikuji Kawata, Yasuo Koike, Yasuo Ishitani
Publikováno v:
Practica Oto-Rhino-Laryngologica. 87:727-731
In a series of 191 patients with chronic paranasal sinusitis 54.4% had foreign-body sensation in the throat (FBST). Roxithromycin (RXM) was administered for about 2 months. The post-arytenoid area was examined for pus and the patients were divided in
Autor:
Yasuo Koike, Ritsuko Abe, Satoshi Hiraga, Shuji Okada, Ikuji Kawata, Tsukasa Takaishi, Yasuo Ishitani, Tatsuya Ishida, Mikio Yamaguchi, Shinya Ohtsu, Fumitoshi Iachibana
Publikováno v:
Practica Oto-Rhino-Laryngologica. 86:1195-1202
Oxatomide was administered to 78 patients (total 86 ears) with otitis media with effusion for four weeks after myringotomy, and its effectiveness and safety were evaluated. The rate of clinical efficacy was 47.7% (marked effect, 15.1%; moderate effec